Printor, a novel torsinA-interacting protein implicated in dystonia pathogenesis

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Early onset generalized dystonia (DYT1) is a neurological disorder.
• It is linked to a mutation in the torsinA protein.
• The exact pathogenic mechanism remains unclear.

Purpose of the Study:

• To identify and characterize novel proteins interacting with torsinA.
• To elucidate the role of these interactions in DYT1 pathogenesis.
• To explore potential therapeutic targets for dystonia.

Main Methods:

• Protein identification and characterization.
• Co-distribution and co-localization studies in brain tissue.
• Analysis of protein-protein interactions using binding assays.
• Investigation of mutation effects on protein interaction.

Main Results:

• A novel 628-amino acid protein, printor, was identified.
• Printor interacts with torsinA and co-localizes in the endoplasmic reticulum.
• Printor binds to the ATP-free form of torsinA.
• The dystonia-associated torsinA DeltaE mutation abolishes printor-torsinA interaction.

Conclusions:

• Printor is a novel cofactor for torsinA.
• Printor is a new component in the DYT1 pathogenic pathway.
• Printor represents a potential molecular target for dystonia therapy.